IP Verse

Hospira competitive analysis

Latest oppositions filed by Hospira

Explore patent oppositions filed by Hospira against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
EP2264047
High Purity Lipopeptides, Lipopeptide Micelles And Processes For Preparing SameCUBIST PHARMACEUTICALSMar 24, 2016

Latest patents of Hospira opposed by its competitors

Explore Hospira's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3046603
Mar 13, 2024Fail-Safe Drug Infusion Therapy System1
EP2766014
Jul 18, 2018Methods Of Treating Pediatric Patients Using Dexmedetomidine1
EP2648520
Apr 11, 2018Dexmedetomidine Premix Formulation1

Latest PTAB cases involving Hospira

Discover the latest PTAB cases involving Hospira, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 4, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Hospira

IPR2017-01054Mar 8, 2017FRESENIUS KABI USAHOSPIRAInstitution Denied
IPR2017-01055Mar 8, 2017FRESENIUS KABI USAHOSPIRAInstitution Denied
IPR2017-01056Mar 8, 2017FRESENIUS KABI USAHOSPIRAInstitution Denied
IPR2017-00804Jan 30, 2017HOSPIRAGENENTECHFinal Written Decision
IPR2017-00804Jan 30, 2017HOSPIRASHAK BAUGHMANFinal Written Decision
IPR2017-00805Jan 30, 2017HOSPIRAGENENTECHFinal Written Decision
IPR2017-00805Jan 30, 2017HOSPIRASHAK BAUGHMANFinal Written Decision
IPR2017-00731Jan 20, 2017HOSPIRAGENENTECHFinal Written Decision
IPR2017-00731Jan 20, 2017HOSPIRAHELLMANNFinal Written Decision
IPR2017-00737Jan 20, 2017HOSPIRAGENENTECHFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Hospira with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HOSPIRA - 387
AMNEAL PHARMACEUTICALS - - 32 -
FRESENIUS KABI USA - - 265
GENENTECH - 127 - 66